TRACON Pharmaceuticals (TCON) Earnings Date, Estimates & Call Transcripts

$1.43
-0.10 (-6.54%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(May. 14)
-$1.33 Missed By -$0.13
Consensus EPS
(May. 14)
-$1.20
Skip Charts & View Estimated and Actual Earnings Data

TCON Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TCON Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TRACON Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.06)($0.06)($0.06)
Q2 20241($0.05)($0.05)($0.05)
Q3 20241($0.04)($0.04)($0.04)
Q4 20241($0.05)($0.05)($0.05)
FY 20244($0.20)($0.20)($0.20)

TCON Earnings Date and Information

TRACON Pharmaceuticals last issued its earnings data on May 14th, 2024. The biopharmaceutical company reported ($1.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.20) by $0.13. The company earned $0.10 million during the quarter. TRACON Pharmaceuticals has generated $0.67 earnings per share over the last year ($0.67 diluted earnings per share) and currently has a price-to-earnings ratio of 2.1. Earnings for TRACON Pharmaceuticals are expected to decrease in the coming year, from ($4.00) to ($5.40) per share. TRACON Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

TRACON Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
Estimated)
------- 
5/14/2024Q1 2024($1.20)($1.33)($0.13)($1.33)-$0.10 million    
3/5/2024Q4 2023($0.60)$0.20+$0.80$0.01$3.00 million$3.41 million
11/9/2023Q3 2023-$5.80+$5.80$0.29--
8/14/2023Q2 2023($7.20)($1.20)+$6.00$0.08-$9.00 million    
5/10/2023Q1 2023($5.80)($7.20)($1.40)($0.36)--    
3/8/2023Q4 2022($5.60)($6.20)($0.60)($0.31)--
11/14/2022Q3 2022($6.00)($6.00)-($0.30)--
8/10/2022Q2 2022($5.80)($6.20)($0.40)($0.31)--
5/11/2022Q1 2022($8.20)($9.60)($1.40)($0.48)--    
3/15/2022Q4 2021($8.00)($8.00)-($0.40)--    
11/3/2021Q3 2021($6.40)($7.60)($1.20)($0.38)--    
8/11/2021Q2 2021($6.80)($11.60)($4.80)($0.58)-$0.35 million    

TRACON Pharmaceuticals Earnings - Frequently Asked Questions

When is TRACON Pharmaceuticals's earnings date?

TRACON Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on TCON's earnings history.

Did TRACON Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, TRACON Pharmaceuticals (NASDAQ:TCON) missed the analysts' consensus estimate of ($1.20) by $0.13 with a reported earnings per share (EPS) of ($1.33). Learn more on analysts' earnings estimate vs. TCON's actual earnings.

How can I listen to TRACON Pharmaceuticals's earnings conference call?

The conference call for TRACON Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read TRACON Pharmaceuticals's conference call transcript?

The conference call transcript for TRACON Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does TRACON Pharmaceuticals generate each year?

TRACON Pharmaceuticals (NASDAQ:TCON) has a recorded annual revenue of $12.05 million.

How much profit does TRACON Pharmaceuticals generate each year?

TRACON Pharmaceuticals (NASDAQ:TCON) has a recorded net income of -$3.59 million. TCON has generated $0.67 earnings per share over the last four quarters.

What is TRACON Pharmaceuticals's price-to-earnings ratio?

TRACON Pharmaceuticals (NASDAQ:TCON) has a trailing price-to-earnings ratio of 2.13.

What is TRACON Pharmaceuticals's EPS forecast for next year?

TRACON Pharmaceuticals's earnings are expected to decrease from ($4.00) per share to ($5.40) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TCON) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners